CAM
PACB icon

Cresset Asset Management’s Pacific Biosciences PACB Stock Holding History

Cresset Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Hold
23,508
– – ﹤0.01% 1715
2026
Q1 		$31K Buy
23,508
+553
+2% +$989 ﹤0.01% 1591
2025
Q4 		$42.9K Hold
22,955
– – ﹤0.01% 1620
2025
Q3 		$29.4K Hold
22,955
– – ﹤0.01% 1546
2025
Q2 		$28.5K Hold
22,955
– – ﹤0.01% 1404
2025
Q1 		$27.1K Sell
22,955
-2,928
-11% -$4.49K ﹤0.01% 1679
2024
Q4 		$47.4K Sell
25,883
-40,890
-61% -$79.8K ﹤0.01% 1672
2024
Q3 		$114K Sell
66,773
-2,280
-3% -$3.75K ﹤0.01% 2036
2024
Q2 		$94.6K Sell
69,053
-9,857
-12% -$19.9K ﹤0.01% 1958
2024
Q1 		$296K Buy
78,910
+15,688
+25% +$91.9K ﹤0.01% 1591
2023
Q4 		$620K Buy
63,222
+6,153
+11% +$50.3K ﹤0.01% 1112
2023
Q3 		$477K Buy
57,069
+6,125
+12% +$70K ﹤0.01% 1207
2023
Q2 		$678K Buy
+50,944
New +$619K ﹤0.01% 1119
2022
Q4 		– Sell
-48,405
Closed -$281K – 843
2022
Q3 		$281K Sell
48,405
-339
-0.7% -$1.95K ﹤0.01% 688
2022
Q2 		$214K Buy
48,744
+687
+1% +$4.17K ﹤0.01% 821
2022
Q1 		$437K Sell
48,057
-2,932
-6% -$33.8K ﹤0.01% 641
2021
Q4 		$1.04M Sell
50,989
-16,118
-24% -$389K 0.01% 442
2021
Q3 		$1.72M Buy
67,107
+250
+0.4% +$7.41K 0.02% 256
2021
Q2 		$2.34M Buy
66,857
+524
+0.8% +$15.2K 0.03% 181
2021
Q1 		$2.21M Buy
+66,333
New +$2.32M 0.04% 166
2020
Q4 		– Sell
-32,000
Closed -$316K – 797
2020
Q3 		$316K Buy
+32,000
New +$184K 0.01% 497

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cresset Asset Management's PACB Position: Q2 2026 in Review

Cresset Asset Management held its Pacific Biosciences (PACB) position steady in Q2 2026 at 23,508 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1715.

Cresset Asset Management first reported a position in PACB in Q3 2020 and has held it in 21 quarters since. The position peaked at $2.34M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Cresset Asset Management held 23,508 shares of Pacific Biosciences worth $39.5K as of Q2 2026.
  • Cresset Asset Management left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1715 holding.
  • Cresset Asset Management first reported a position in Pacific Biosciences in Q3 2020 and has held it in 21 quarters since.
  • Cresset Asset Management's Pacific Biosciences position peaked at $2.34M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.